Back to Search Start Over

A meglumine catalyst–based synthesis, molecular docking, and antioxidant studies of dihydropyrano[3, 2‐<scp>b</scp>]chromenedione derivatives

Authors :
G. Suresh
Wudayagiri Rajendra
Chintha Venkataramaiah
N. Bakthavatchala Reddy
Grigory V. Zyryanov
C. Suresh Reddy
Avula Balakrishna
G. Sravya
K. Madhu Kumar Reddy
Source :
Journal of Heterocyclic Chemistry
Publication Year :
2019
Publisher :
Wiley, 2019.

Abstract

A simple method was employed for the synthesis of dihydropyrano[3, 2-b]chromenedione derivatives (4a-o) in high yields by condensation of 5, 5-dimethylcyclohexane-1, 3-dione(1), different aromatic aldehydes (2a-o), and 5-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one(3), using meglumine as a stable and reusable catalyst. Meglumine, an amino sugar, was employed as an environmentally benign catalyst, due to its splendid properties such as being inexpensive, recyclable, and biodegradable. The accomplished protocol employs low catalyst loading and easy work-up for the synthesis of 5-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one derivatives. A great asset is that without any significant loss, the catalyst could be recovered and reused for extended synthetic steps. This offer huge advantage to overcome recyclability issues. Our synthesized compounds were analyzed by IR, 1H, 13C NMR, mass spectra and evaluated for their antioxidant properties by 1, 1-diphenyl-2-picryl hydrazyl radical (DPPH), hydrogen peroxide(H2O2), and nitric oxide (NO) scavenging methods. The correlation in exhibition of antioxidant activity was effective at all doses. The binding interactions and molecular docking studies for entitled compounds were studied against 3MNG protein; 4k exhibited marked binding affinity with excellent docking score of −7.6 Kcal/mol and emerged as a lead compound. &#169; 2019 Wiley Periodicals, Inc. Ural Federal University, UrFU The authors G. Sravya and N. Bakthavatchala Reddy are thankful to Ural Federal University, Yekaterinburg, Russia, for postdoctoral fellowship.

Subjects

Subjects :
2 (HYDROXYMETHYL) 7,7 DIMETHYL 10 (3,4,5 TRIMETHOXYPHENYL) 7,8 DIHYDROPYRANO[3,2 B]CHROMENE 4,9 (6H,10H)DIONE
DPPH RADICAL SCAVENGING ASSAY
MASS SPECTROMETRY
Antioxidant
2 (HYDROXYMETHYL) 10 (4 METHOXYPHENYL) 7,7 DIMETHYL 7,8 DIHYDROPYRANO[3,2 B]CHROMENE 4,9 (6H,10H)DIONE
SCORING SYSTEM
medicine.medical_treatment
DRUG SCREENING
10 (4 BROMOPHENYL) 2 (HYDROXYMETHYL) 7,7 DIMETHYL 10 PHENYL 7,8 DIHYDROPYRANO[3,2 B]CHROMENE 4,9 (6H,10H)DIONE
UNCLASSIFIED DRUG
2 (HYDROXYMETHYL) 7,7 DIMETHYL 10 (2 NITROPHENYL) 7,8 DIHYDROPYRANO[3,2 B]CHROMENE 4,9 (6H,10H)DIONE
chemistry.chemical_compound
ANTIOXIDANT
DRUG ABSORPTION
2 (HYDROXYMETHYL) 7,7 DIMETHYL 10 (4 NITROPHENYL) 7,8 DIHYDROPYRANO[3,2 B]CHROMENE 4,9 (6H,10H)DIONE
MOLECULAR DOCKING
NITRICOXIDE SCAVENGING ASSAY
HYDROGEN PEROXIDE
OXIDATIVE STRESS
CHROMENE DERIVATIVE
CATALYST
Meglumine
Chemistry
HUMAN
DIHYDROPYRANO[3,2 B]CHROMENEDIONE DERIVATIVE
2 (HYDROXYMETHYL) 7,7 DIMETHYL 10 (2 PHENOXYPHENYL) 7,8 DIHYDROPYRANO[3,2 B]CHROMENE 4,9 (6H,10H)DIONE
BINDING AFFINITY
2 (HYDROXYMETHYL) 7,7 DIMETHYL 10 (4 TOLYL) 7,8 DIHYDROPYRANO[3,2 B]CHROMENE 4,9 (6H,10H)DIONE
ASCORBIC ACID
INFRARED SPECTROSCOPY
NITRIC OXIDE
IN VITRO STUDY
DRUG ISOLATION
medicine.drug
10 (4 CHLOROPHENYL) 2 (HYDROXYMETHYL) 7,7 DIMETHYL 10 PHENYL 7,8 DIHYDROPYRANO[3,2 B]CHROMENE 4,9 (6H,10H)DIONE
CARBON NUCLEAR MAGNETIC RESONANCE
10 [4 (DIMETHYLAMINO)PHENYL] 2 (HYDROXYMETHYL) 7,7 DIMETHYL 10 PHENYL 7,8 DIHYDROPYRANO[3,2 B]CHROMENE 4,9 (6H,10H)DIONE
HYDROGEN PEROXIDE SCAVENGING ASSAY
Catalysis
LEAD
2 (HYDROXYMETHYL) 7,7 DIMETHYL 10 (3 NITROPHENYL) 7,8 DIHYDROPYRANO[3,2 B]CHROMENE 4,9 (6H,10H)DIONE
medicine
NONHUMAN
10 (4 FLUOROPHENYL) 2 (HYDROXYMETHYL) 7,7 DIMETHYL 10 PHENYL 7,8 DIHYDROPYRANO[3,2 B]CHROMENE 4,9 (6H,10H)DIONE
ARTICLE
Efficient catalyst
2 (HYDROXYMETHYL) 7,7 DIMETHYL 10 PHENYL 7,8 DIHYDROPYRANO[3,2 B]CHROMENE 4,9 (6H,10H)DIONE
2 (HYDROXYMETHYL) 10 (4 HYDROXYPHENYL) 7,7 DIMETHYL 7,8 DIHYDROPYRANO[3,2 B]CHROMENE 4,9 (6H,10H)DIONE
10 (3,5 DIMETHOXYPHENYL) 2 (HYDROXYMETHYL) 7,7 DIMETHYL 10 PHENYL 7,8 DIHYDROPYRANO[3,2 B]CHROMENE 4,9 (6H,10H)DIONE
ANTIOXIDANT ASSAY
DRUG SYNTHESIS
Organic Chemistry
2 (HYDROXYMETHYL) 7,7 DIMETHYL 10 (PYRIDIN 2 YL) 7,8 DIHYDROPYRANO[3,2 B]CHROMENE 4,9 (6H,10H)DIONE
Combinatorial chemistry
DRUG BIOAVAILABILITY
CONTROLLED STUDY
PROTON NUCLEAR MAGNETIC RESONANCE
ANIMAL CELL
MEGLUMINE
Kojic acid
ANTIOXIDANT ACTIVITY

Details

ISSN :
19435193 and 0022152X
Volume :
57
Database :
OpenAIRE
Journal :
Journal of Heterocyclic Chemistry
Accession number :
edsair.doi.dedup.....1601b55f3b3dda872e0c9bdf3ca67d35
Full Text :
https://doi.org/10.1002/jhet.3786